Astria Therapeutics, Inc.ATXSNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-111.56M
↓ 78% below average
Average (9y)
$-62.83M
Historical baseline
Range
High:$-26.37M
Low:$-194.98M
CAGR
+15.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-111.56M | -34.4% |
| 2023 | $-83.03M | -55.2% |
| 2022 | $-53.50M | +72.6% |
| 2021 | $-194.98M | -420.8% |
| 2020 | $-37.44M | -38.2% |
| 2019 | $-27.09M | -2.7% |
| 2018 | $-26.37M | +2.7% |
| 2017 | $-27.09M | +23.8% |
| 2016 | $-35.56M | -12.3% |
| 2015 | $-31.66M | - |